# Panacent Bio Inc. — Form D

Panacent Bio Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-12. The offering totals $13, of which $13 was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-07-12
- Form: D
- Accession: 0002030065-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $13
- Amount sold: $13
- Investors: 1
- Date of first sale: 2024-06-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-518567

## Issuer

- Name: Panacent Bio Inc.
- CIK: 0002030065
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 666 GREENWICH STREET 744, NEW YORK, NY, 10014
- Phone: 415-710-9061

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Robert Sebra | Director | New York, NY |
| Daniel Charytonowicz | Executive Officer | New York, NY |
| Robert Sebra | Executive Officer | New York, NY |

## More

- [CIK 2030065 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2030065&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002030065-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.